RESUMEN
Bacillus Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis (M. bovis), is the lead candidate vaccine for control of bovine tuberculosis (TB) in cattle. However, BCG vaccination sensitises cattle to bovine tuberculin, thus compromising the use of the current bovine TB surveillance tests. To address this, we have developed a diagnostic skin test that is not compromised by BCG vaccination and is able to detect BCG vaccinated animals that subsequently develop bovine TB following exposure to M. bovis. Building on previous work using 'in house' formulated protein cocktail reagents, we herein present test performance data for a single fusion protein (DST-F) containing the mycobacterial antigens ESAT-6, CFP-10 and Rv3615c formulated as a 'ready to use' reagent by a commercial manufacturer. Our results demonstrate that, unlike tuberculin reagents, a diagnostic skin test using DST-F maintained high specificity in BCG vaccinated animals. Furthermore, the DST-F skin test demonstrated a high relative sensitivity in identifying M. bovis infected animals, including those where BCG vaccination failed to prevent bovine TB pathology following experimental exposure to M. bovis. The DST-F is currently undergoing field trials in Great Britain to support its licensure and commercialisation.
Asunto(s)
Mycobacterium bovis , Tuberculosis Bovina , Animales , Antígenos Bacterianos , Vacuna BCG , Bovinos , Indicadores y Reactivos , Pruebas Cutáneas , Tuberculina , Tuberculosis Bovina/diagnóstico , Tuberculosis Bovina/prevención & control , Vacunación/veterinariaRESUMEN
Bovine tuberculosis (bTB) is a disease of livestock with severe and worldwide economic, animal welfare and zoonotic consequences. Application of test-and-slaughter-based control polices reliant on tuberculin skin testing has been the mainstay of bTB control in cattle. However, little is known about the temporal development of the bovine tuberculin skin test response at the dermal sites of antigen injection. To fill this knowledge gap, we applied minimally-invasive sampling microneedles (SMNs) for intradermal sampling of interstitial fluid at the tuberculin skin test sites in Mycobacterium bovis BCG-vaccinated calves and determined the temporal dynamics of a panel of 15 cytokines and chemokines in situ and in the peripheral blood. The results reveal an orchestrated and coordinated cytokine and local chemokine response, identified IL-1RA as a potential soluble biomarker of a positive tuberculin skin response, and confirmed the utility of IFN-γ and IP-10 for bTB detection in blood-based assays. Together, the results highlight the utility of SMNs to identify novel biomarkers and provide mechanistic insights on the intradermal cytokine and chemokine responses associated with the tuberculin skin test in BCG-sensitized cattle.
Asunto(s)
Vacuna BCG/administración & dosificación , Citocinas/biosíntesis , Agujas , Tuberculina/administración & dosificación , Animales , BovinosRESUMEN
Tuberculin Purified Protein Derivatives (PPDs) exhibit multiple limitations: they are crude extracts from mycobacterial cultures with largely unknown active components; their production depends on culture of mycobacteria requiring expensive BCL3 production facilities; and their potency depends on the technically demanding guinea pig assay. To overcome these limitations, we developed a molecularly defined tuberculin (MDT) by adding further antigens to our prototype reagent composed of ESAT-6, CFP-10 and Rv3615c (DIVA skin test, DST). In vitro screening using PBMC from infected and uninfected cattle shortlisted four antigens from a literature-based list of 18 to formulate the MDT. These four antigens plus the previously identified Rv3020c protein, produced as recombinant proteins or overlapping synthetic peptides, were formulated together with the three DST antigens into the MDT to test cattle experimentally and naturally infected with M. bovis, uninfected cattle and MAP vaccinated calves. We demonstrated significant increases in MDT-induced skin responses compared to DST in infected animals, whilst maintaining high specificity in unvaccinated or MAP vaccinated calves. Further, MDT can also be applied in in vitro blood-based interferon-gamma release assays. Thus, MDT promises to be a robust diagnostic skin and blood test reagent overcoming some of the limitations of PPDs and warrants full validation.
Asunto(s)
Mycobacterium bovis/aislamiento & purificación , Paratuberculosis/prevención & control , Prueba de Tuberculina/veterinaria , Tuberculina/inmunología , Tuberculosis Bovina/diagnóstico , Animales , Bovinos , Leucocitos Mononucleares , Masculino , Mycobacterium avium subsp. paratuberculosis/inmunología , Mycobacterium bovis/inmunología , Paratuberculosis/microbiología , Prueba de Tuberculina/métodos , Tuberculosis Bovina/inmunología , Tuberculosis Bovina/microbiología , Vacunación/veterinariaRESUMEN
Bovine tuberculosis (bTB), caused by Mycobacterium bovis, is a chronic disease of cattle with a detrimental impact on food quality and production. Research on bTB vaccines has predominantly been focused on proteinaceous antigens. However, mycobacteria have a thick and intricate lipid outer layer and lipids as well as lipopeptides are important for immune-evasion and virulence. In humans, lipid extracts of M. tuberculosis have been shown to elicit immune responses effective against M. tuberculosisin vitro. Chloroform-methanol extraction (CME) was applied to M. bovis BCG to obtain a hydrophobic antigen extract (CMEbcg) containing lipids and lipopeptides. CMEbcg stimulated IFN-γ+IL-2+ and IL-17A+IL-22+ polyfunctional T cells and elicited T cell responses with a Th1 and Th17 cytokine release profile in both M. bovis BCG vaccinated and M. bovis challenged calves. Lipopeptides were shown to be the immunodominant antigens in CMEbcg, stimulating CD4 T cells via MHC class II. CMEbcg expanded T cells killed CMEbcg loaded monocytes and the CMEbcg-specific CD3 T cell proliferative response following M. bovis BCG vaccination was the best predictor for reduced pathology following challenge with M. bovis. Although the high predictive value of CMEbcg-specific immune responses does not confirm a causal relationship with protection against M. bovis challenge, when taking into account the in vitro antimycobacterial phenotype of CMEbcg-specific T cells (e.g. Th1/Th17 cytokine profile), it is indicative that CMEbcg-specific immune responses could play a functional role in immunity against M. bovis. Based on these findings we conclude that lipopeptides of M. bovis are potential novel subunit vaccine candidates and that further studies into the functional characterization of lipopeptide-specific immune responses together with their role in protection against bovine tuberculosis are warranted.
Asunto(s)
Antígenos Bacterianos/inmunología , Vacuna BCG/administración & dosificación , Lipopéptidos/inmunología , Mycobacterium bovis/inmunología , Linfocitos T/inmunología , Vacunas de Subunidad/administración & dosificación , Animales , Anticuerpos Antibacterianos/inmunología , Bovinos/inmunología , Citocinas/inmunología , Interacciones Hidrofóbicas e Hidrofílicas , Inmunización , MasculinoRESUMEN
Human studies have identified the potential of measuring Mycobacterium tuberculosis specific IFN-γ and/or IL-2 secreting T cell subsets to distinguish different clinical stages of human tuberculosis (TB). To assess these functional T cell subsets in different states of bovine TB we have established a bovine dual IFN-γ/IL-2 fluorescence-immunospot (FluoroSpot) assay and analysed the frequencies of Mycobacterium bovis (M. bovis) specific IL-2 and/or IFN-γ producing cells in PBMC from 30 cattle naturally infected with M. bovis. Depending on their post mortem results the animals were grouped in 22 cattle with visible lesions (VL) and 8 cattle without visible lesions (NVL). In response to bovine tuberculin purified protein derivative (PPD-B) the frequencies of cytokine producing cells and proportions of IL-2 single producers were significantly higher in VL compared to NVL while PWM-induced cytokine responses were similar between the two groups. Dual IL-2+IFN-γ+ T cells could be identified as the largest PPD-B responsive T cell subset in both cattle groups. In conclusion, our FluoroSpot is a valid method to enumerate individual antigen-specific IFN-γ+ and IL-2+ T cell subsets ex vivo. The greater levels of single IL-2 producing T cells associated with the presence of pathology could be a potential biomarker for active TB in cattle.
Asunto(s)
Ensayo de Immunospot Ligado a Enzimas/veterinaria , Fluorescencia , Interferón gamma/inmunología , Interleucina-2/inmunología , Tuberculosis Bovina/diagnóstico , Tuberculosis Bovina/inmunología , Animales , Antígenos Bacterianos/inmunología , Bovinos , Color , Mycobacterium bovis/inmunología , Subgrupos de Linfocitos T/inmunologíaRESUMEN
Bovine tuberculosis (bTB) is a major zoonotic disease of cattle that is endemic in much of the world, limiting livestock productivity and representing a global public health threat. Because the standard tuberculin skin test precludes implementation of Bacille Calmette-Guérin (BCG) vaccine-based control programs, we here developed and evaluated a novel peptide-based defined antigen skin test (DST) to diagnose bTB and to differentiate infected from vaccinated animals (DIVA). The results, in laboratory assays and in experimentally or naturally infected animals, demonstrate that the peptide-based DST provides DIVA capability and equal or superior performance over the extant standard tuberculin surveillance test. Together with the ease of chemical synthesis, quality control, and lower burden for regulatory approval compared with recombinant antigens, the results of our studies show that the DST considerably improves a century-old standard and enables the development and implementation of critically needed surveillance and vaccination programs to accelerate bTB control.
Asunto(s)
Antígenos Bacterianos/inmunología , Bovinos/microbiología , Pruebas Cutáneas , Tuberculosis Bovina/diagnóstico , Tuberculosis Bovina/inmunología , Animales , Interferón gamma/metabolismo , Péptidos/inmunología , Prueba de TuberculinaRESUMEN
Bovine tuberculosis (BTB) is a disease of economic and zoonotic importance caused mainly by Mycobacterium bovis. In addition to the tuberculin skin test, an interferon-gamma (IFN-γ) release assay (IGRA) blood test has been incorporated in the BTB control programs of numerous countries as an ancillary test to the skin test. A potential disadvantage of the IGRA assay is that it relies solely on the measurement of a single readout (i.e. IFN-γ) for the detection of BTB. In this study we have assessed the practical use of CXCL10 as an additional biomarker for the diagnosis of BTB in the setting of the current testing approach alongside IGRA. To do so, we have assessed both IFN-γ and CXCL10 readouts in blood cultures from a variety of different BTB cattle groups stimulated with standard tuberculin reagents and also with more specific defined antigens (ESAT-6, CFP-10 and Rv3615c). When using a tuberculin based whole blood assay, CXCL10 alone could not substitute for IFN-γ as the analyte measured in the test without reducing the sensitivity of detecting BTB animals. However, when used as an additional test readout, CXCL10 identified BTB animals that failed to induce IFN-γ responses. When tested in non-infected animals, the use of the dual biomarker system had the potential to lower overall test specificity, however this could be overcome by raising the cut-off values for CXCL10 test positivity. Taken together, the results demonstrate that in particular settings, measurement of CXCL10 has the potential to complement the current use of IFN-γ in blood assays to maximise the detection of BTB.
Asunto(s)
Quimiocina CXCL10/sangre , Interferón gamma/sangre , Tuberculosis Bovina/diagnóstico , Tuberculosis Bovina/inmunología , Animales , Antígenos Bacterianos/inmunología , Proteínas Bacterianas/inmunología , Biomarcadores/sangre , Bovinos , Ensayo de Inmunoadsorción Enzimática/veterinaria , Ensayos de Liberación de Interferón gamma/veterinaria , Mycobacterium bovis/inmunología , Sensibilidad y Especificidad , Pruebas Serológicas/veterinaria , Prueba de Tuberculina/veterinaria , Reino UnidoRESUMEN
There is a need to improve the efficacy of the BCG vaccine against human and bovine tuberculosis. Previous data showed that boosting bacilli Calmette-Guerin (BCG)-vaccinated cattle with a recombinant attenuated human type 5 adenovirally vectored subunit vaccine (Ad5-85A) increased BCG protection and was associated with increased frequency of Ag85A-specific CD4+ T cells post-boosting. Here, the capacity of Ag85A-specific CD4+ T cell lines - derived before and after viral boosting - to interact with BCG-infected macrophages was evaluated. No difference before and after boosting was found in the capacity of these Ag85A-specific CD4+ T cell lines to restrict mycobacterial growth, but the secretion of IL-10 in vitro post-boost increased significantly. Furthermore, cell lines derived post-boost had no statistically significant difference in the secretion of pro-inflammatory cytokines (IL-1ß, IL-12, IFNγ or TNFα) compared to pre-boost lines. In conclusion, the protection associated with the increased number of Ag85A-specific CD4+ T cells restricting mycobacterial growth may be associated with anti-inflammatory properties to limit immune-pathology.
Asunto(s)
Aciltransferasas/inmunología , Antígenos Bacterianos/inmunología , Inmunización Secundaria/métodos , Inflamación/prevención & control , Mycobacterium bovis/inmunología , Vacunas contra la Tuberculosis/inmunología , Tuberculosis Bovina/prevención & control , Aciltransferasas/administración & dosificación , Adenovirus Humanos/genética , Animales , Antígenos Bacterianos/administración & dosificación , Linfocitos T CD4-Positivos/inmunología , Bovinos , Portadores de Fármacos , Inflamación/microbiología , Inflamación/patología , Mycobacterium bovis/crecimiento & desarrollo , Resultado del Tratamiento , Vacunas contra la Tuberculosis/administración & dosificación , Tuberculosis Bovina/microbiología , Tuberculosis Bovina/patología , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/inmunologíaRESUMEN
In this study we investigated whether oral uptake of a heat inactivated M. bovis wildlife vaccine by domestic cattle induced systemic immune responses that compromised the use of tuberculin or defined antigens in diagnostic tests for bovine TB. Positive skin test and blood-based IFN-γ release assay (IGRA) results were observed in all calves vaccinated via the parenteral route (i.e. intramuscular). In contrast, no positive responses to tuberculin or defined antigens were observed in either the skin test or IGRA test when performed in calves vaccinated via the oral route. In conclusion, our results suggest that the heat inactivated M. bovis vaccine could be used to vaccinate wildlife in a baited form in conjunction with the following in cattle: (i) continuation of existing tuberculin skin testing or novel skin test formats based on defined antigens; and (ii) the use of IGRA tests utilizing tuberculin or defined antigens.
Asunto(s)
Mycobacterium bovis/inmunología , Tuberculosis Bovina/diagnóstico , Administración Oral , Animales , Animales Salvajes/inmunología , Animales Salvajes/microbiología , Vacuna BCG/administración & dosificación , Bovinos , Reservorios de Enfermedades/microbiología , Calor , Interferón gamma/sangre , Prueba de Tuberculina/métodos , Prueba de Tuberculina/veterinaria , Tuberculosis Bovina/inmunología , Tuberculosis Bovina/prevención & control , Vacunación/métodos , Vacunación/veterinaria , Vacunas de Productos Inactivados/administración & dosificaciónRESUMEN
There is a need to improve the efficacy of Bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans and cattle. Previously, we found boosting BCG-primed cows with recombinant human type 5 adenovirus expressing antigen 85A (Ad5-85A) increased protection against Mycobacterium bovis infection compared to BCG vaccination alone. The aim of this study was to decipher aspects of the immune response associated with this enhanced protection. We compared BCG-primed Ad5-85A-boosted cattle with BCG-vaccinated cattle. Polyclonal CD4(+) T cell libraries were generated from pre-boost and post-boost peripheral blood mononuclear cells - using a method adapted from Geiger et al. (2009) - and screened for antigen 85A (Ag85A) specificity. Ag85A-specific CD4(+) T cell lines were analysed for their avidity for Ag85A and their Ag85A epitope specificity was defined. Boosting BCG with Ad5-85A increased the frequencies of post-boost Ag85A-specific CD4(+) T cells which correlated with protection (reduced pathology). Boosting Ag85A-specific CD4(+) T cell responses did not increase their avidity. The epitope specificity was variable between animals and we found no clear evidence for a post-boost epitope spreading. In conclusion, the protection associated with boosting BCG with Ad5-85A is linked with increased frequencies of Ag85A-specific CD4(+) T cells without increasing avidity or widening of the Ag85A-specific CD4(+) T cell repertoire.
Asunto(s)
Aciltransferasas/inmunología , Antígenos Bacterianos/inmunología , Vacuna BCG/inmunología , Linfocitos T CD4-Positivos/inmunología , Tuberculosis/prevención & control , Animales , Bovinos , Epítopos de Linfocito T/inmunología , Femenino , Leucocitos Mononucleares/inmunología , Mycobacterium bovisRESUMEN
Gene transcription studies have identified dual roles for the cytokines IL-17A and IL-22 in bovine tuberculosis, where they show potential as both predictors of vaccine success and correlates of infection. To allow for a detailed investigation of the cell populations responsible for production of these cytokines, we have utilised a novel bovine IL-22 specific recombinant antibody for flow cytometry. Bovine tuberculin (PPDB) induced greater IL-22 and IL-17A production in Mycobacterium bovis (M. bovis)-infected cattle compared to non-infected controls, while PWM-induced cytokine levels were similar between the two groups. In M. bovis-infected animals, PPDB specific IL-22 and IL-17A responses were observed in both CD4+ T cell and γδ T cell populations. Although both cytokines were detected in both cell types, IL-22/IL-17A double producers were rare and confined mainly to the γδ T cell population. These results support previous gene transcription studies and extend the observation of increased IL-22 and IL-17A responses in M. bovis-infected animals to the level of protein production. We were also able to characterise the cell populations responsible for these disease-related cytokine responses. The data generated can be used to further our understanding of the immunopathology of bovine tuberculosis and to produce more sensitive and specific immune-diagnostic reagents.
Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Interleucina-17/metabolismo , Interleucinas/metabolismo , Mycobacterium bovis/fisiología , Receptores de Antígenos de Linfocitos T gamma-delta/inmunología , Tuberculosis Bovina/inmunología , Tuberculosis Bovina/microbiología , Animales , Bovinos , Humanos , Células Asesinas Naturales/metabolismo , Interleucina-22RESUMEN
OBJECTIVES: The aim of our study was to elucidate how cyclic mechanical stretch is sensed by cardiomyocytes and in which way it affects cytoskeletal organization. METHODS: Neonatal rat cardiomyocytes, cultured on flexible membranes, were subjected to cyclic mechanical stretch (1 Hz, 10% elongation) for 24 h using either round or rectangular loading posts for equibi-axial or uni-axial stretch, respectively, using the FlexCell stretch system. Cells were treated either with vehicle, the focal adhesion kinase (FAK) inhibitor PF-573,228 (200 nM), or the stretch-activated ion channel blocker gadolinium (Gd(3+); 100 µM). RESULTS: Cyclic mechanical stretch (36 mm diameter silicone membrane, equibi-axial stretch, 10% elongation, 1 Hz) induced elongation of the cardiomyocytes together with accentuation of Cx43 at the cell poles, and with an orientation of the cell axis between the radial axis and the circumferential axis (mean deviation: 11° from the circumference). Moreover, stretch resulted in ca. 1.4 fold increased Cx43 expression. FAK was found to be phosphorylated at the edges of the cells. In order to find out, how cardiomyocytes might sense stretch, we investigated possible effects of Gd(3+)and PF-573,228. Gd(3+) had no effect on elongation or polarization and did not affect stretch-induced Cx43 expression. Interestingly, the FAK inhibitor completely antagonized the stretch-induced elongation, orientation and Cx43-polarization. However, the stretch-induced Cx43 expression was insensitive to this treatment. In order to clarify our result that the cells in equibi-axial stretch did not exactly organize to the circumference or to the radial axis, we decided to use a uni-axial stretch protocol. In uni-axially stretched cells, we found that the cardiomyocytes also showed elongation, Cx43 polarization, and orientation near to the stretch axis, but not exactly in the stretch axis but ca. 25° oblique to it. Furthermore, we investigated the tubular system, the Golgi apparatus, the SR and the nucleus. After 24 h stretch the microtubules were localized nearly (but not completely) parallel to the stretch axis (i.e. in longitudinal cell axis). Moreover, the localization of nucleus and the Golgi was also changed: while under static conditions, the Golgi was distributed more or less around the nucleus, after stretch the Golgi was accentuated at one site of the nucleus facing a cell pole with the nucleus facing the opposite cell pole. The plus motor protein kinesin accentuated at the cell poles and at the cell periphery, while the minus motor protein dynein was found near to the Golgi apparatus. CONCLUSIONS: The stretch signal sensing is mediated via FAK and leads to intracellular re-organization and orientation. The oblique orientation of the cell with regard to the direction of stretch may define a directed force vector which could allow the cell to orientate.
Asunto(s)
Citoesqueleto/fisiología , Canales Iónicos/fisiología , Mecanotransducción Celular/fisiología , Proteínas Motoras Moleculares/fisiología , Miocitos Cardíacos/citología , Miocitos Cardíacos/fisiología , Animales , Células Cultivadas , Proteínas del Citoesqueleto/metabolismo , Activación del Canal Iónico/fisiología , Estimulación Física/métodos , Ratas , Estrés MecánicoRESUMEN
We describe here the application of a novel bovine interleukin-2 (IL-2) enzyme-linked immunosorbent assay (ELISA) for the measurement of antigen-specific IL-2 in cattle naturally infected with Mycobacterium bovis and in cattle vaccinated with Mycobacterium bovis BCG and then experimentally challenged with pathogenic M. bovis. Supernatants from whole-blood cultures stimulated with mycobacterial antigen (bovine purified protein derivative [PPDB] or the peptide cocktail ESAT6-CFP10) were assessed using a sandwich ELISA consisting of a new recombinant monoclonal fragment capture antibody and a commercially available polyclonal anti-bovine-IL-2. The production of IL-2 was compared to the production of gamma interferon (IFN-γ) in the same antigen-stimulated whole-blood supernatants. The data show that cattle infected with M. bovis produced quantifiable levels of antigen-specific IL-2, while IL-2 levels in cattle vaccinated with M. bovis BCG did not. Furthermore, cattle vaccinated with M. bovis BCG and then challenged with pathogenic M. bovis displayed a more rapid induction of IL-2 but ultimately had lower levels of infection-induced IL-2 than did unvaccinated challenge control cattle. These data suggest that IL-2 responses are not detectable post-BCG vaccination and that these responses may require infection with virulent M. bovis to develop. This may be useful to differentiate infected cattle from uninfected or BCG-vaccinated cattle, although the overall sensitivity is relatively low, particularly in single intradermal comparative cervical tuberculin (SICCT)-negative infected animals. Furthermore, the strength of the IL-2 response may correlate with pathology, which poses interesting questions on the immunobiology of bovine tuberculosis in contrast to human tuberculosis, which is discussed.
Asunto(s)
Vacuna BCG/inmunología , Técnicas de Laboratorio Clínico/métodos , Interleucina-2/análisis , Mycobacterium bovis/inmunología , Tuberculosis Bovina/diagnóstico , Tuberculosis Bovina/inmunología , Medicina Veterinaria/métodos , Animales , Vacuna BCG/administración & dosificación , Bovinos , Células Cultivadas , Diagnóstico Diferencial , Ensayo de Inmunoadsorción Enzimática/métodos , Interferón gamma/metabolismo , Interleucina-2/metabolismo , Leucocitos Mononucleares/inmunologíaRESUMEN
In this study we have investigated the potential of mycobacterial proteins as candidate subunit vaccines for bovine tuberculosis. In addition, we have explored the use of TLR-ligands as potential adjuvants in cattle. In vitro screening assays with whole blood from Mycobacterium bovis-infected and BCG-vaccinated cattle demonstrated that fusion protein constructs were most commonly recognised, and the ID83 fusion protein was selected for further immunisation studies. Furthermore, glucopyranosyl lipid A (GLA) and resiquimod (R848), agonists for TLR4 and TLR7/8 respectively, stimulated cytokine production (IL-12, TNF-α, MIP-1ß and IL-10) in bovine dendritic cell cultures, and these were formulated as novel oil-in-water emulsions (GLA-SE and R848-SE) for immunisation studies. Immunisation with ID83 in a water-in-oil emulsion adjuvant (ISA70) induced both cell mediated and humoral immune responses, as characterised by antigen-specific IFN-γ production, cell proliferation, IgG1 and IgG2 antibody production. In comparison, ID83 immunisation with the novel adjuvants induced weaker (ID83/R848-SE) or no (ID83/GLA-SE) antigen-specific IFN-γ production and cell proliferation. However, both did induce ID83-specific antibody production, which was restricted to IgG1 antibody isotype. Overall, these results provide encouraging preliminary data for the further development of ID83 in vaccine strategies for bovine TB.
Asunto(s)
Antígenos Bacterianos/inmunología , Inmunidad Celular , Inmunidad Humoral , Mycobacterium bovis/inmunología , Vacunas contra la Tuberculosis/inmunología , Tuberculosis Bovina/prevención & control , Adyuvantes Inmunológicos/administración & dosificación , Animales , Anticuerpos Antibacterianos/sangre , Antígenos Bacterianos/genética , Bovinos , Proliferación Celular , Imidazoles/administración & dosificación , Inmunoglobulina G/sangre , Interferón gamma/metabolismo , Leucocitos Mononucleares/inmunología , Lípido A/administración & dosificación , Lípido A/análogos & derivados , Proteínas Recombinantes de Fusión/genética , Proteínas Recombinantes de Fusión/inmunología , Vacunas contra la Tuberculosis/administración & dosificación , Vacunas contra la Tuberculosis/genética , Vacunas de Subunidad/administración & dosificación , Vacunas de Subunidad/genética , Vacunas de Subunidad/inmunología , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/genética , Vacunas Sintéticas/inmunologíaRESUMEN
Mycobacterial lipids have long been known to modulate the function of a variety of cells of the innate immune system. Here, we report the extraction and characterisation of polar and apolar free lipids from Mycobacterium bovis AF 2122/97 and identify the major lipids present in these fractions. Lipids found included trehalose dimycolate (TDM) and trehalose monomycolate (TMM), the apolar phthiocerol dimycocersates (PDIMs), triacyl glycerol (TAG), pentacyl trehalose (PAT), phenolic glycolipid (PGL), and mono-mycolyl glycerol (MMG). Polar lipids identified included glucose monomycolate (GMM), diphosphatidyl glycerol (DPG), phenylethanolamine (PE) and a range of mono- and di-acylated phosphatidyl inositol mannosides (PIMs). These lipid fractions are capable of altering the cytokine profile produced by fresh and cultured bovine monocytes as well as monocyte derived dendritic cells. Significant increases in the production of IL-10, IL-12, MIP-1ß, TNFα and IL-6 were seen after exposure of antigen presenting cells to the polar lipid fraction. Phenotypic characterisation of the cells was performed by flow cytometry and significant decreases in the expression of MHCII, CD86 and CD1b were found after exposure to the polar lipid fraction. Polar lipids also significantly increased the levels of CD40 expressed by monocytes and cultured monocytes but no effect was seen on the constitutively high expression of CD40 on MDDC or on the levels of CD80 expressed by any of the cells. Finally, the capacity of polar fraction treated cells to stimulate alloreactive lymphocytes was assessed. Significant reduction in proliferative activity was seen after stimulation of PBMC by polar fraction treated cultured monocytes whilst no effect was seen after lipid treatment of MDDC. These data demonstrate that pathogenic mycobacterial polar lipids may significantly hamper the ability of the host APCs to induce an appropriate immune response to an invading pathogen.
Asunto(s)
Citocinas/genética , Inmunidad Innata , Lípidos/farmacología , Mycobacterium bovis/inmunología , Tuberculosis Bovina/inmunología , Animales , Antígenos de Superficie/metabolismo , Bovinos , Proliferación Celular , Citocinas/metabolismo , Células Dendríticas/inmunología , Regulación hacia Abajo , Monocitos/microbiología , Linfocitos T/metabolismo , Tuberculosis Bovina/microbiologíaRESUMEN
Upon stimulation, leukocytes secrete chemokines to attract distinct effector cell populations to the site of inflammation. Only a few data are available about the phenotype and the frequencies of cells expressing particular chemokines. To date, the expression of individual chemokines is mainly analyzed at the mRNA level or via ELISA. Both techniques do not allow the analysis of chemokines at the level of single cells. We have established the intracellular flow-cytometric detection of the murine chemokines macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, regulated on activation normal T cell expressed and secreted (RANTES) and activation-induced, T cell-derived and chemokine-related cytokine (ATAC)/lymphotactin. For detection of the nonclassical chemokine ATAC, we generated the novel mAb MTAC-2. Using this assay, we analyzed for the first time the frequency and kinetics of the expression of these murine chemokines in lymphocyte subpopulations. We show that these chemokines are differentially expressed by NK cells, naive and memory CD4(+) and CD8(+) T cells. Our results emphasize that the analysis of chemokine expression at the single-cell level is required to understand the functional role of specialized lymphocyte subpopulations in vivo.